Unbiased AI-powered news
Three women described their experiences seeking care after treatment left them in menopause. Physicians noted evolving options but persistent barriers for survivors.
nypost.comBreast cancer survivors are encountering repeated refusals when seeking hormone therapies and other menopause treatments, Usa Today reported. Erika Wurth found a lump in her right breast just after turning 50 and was diagnosed last year. She underwent a lumpectomy, four rounds of chemotherapy and a double mastectomy, then experienced medication-induced menopause.
Wurth cold capped her waist-length hair before cutting it into a pixie, changed her diet and began lifting weights seven days a week. Her initial doctor refused hormone replacement therapy, and two additional physicians declined to discuss hormones. A urologist later prescribed estrogen gel, oral progesterone and vaginal estrogen cream.
Paulina Teng learned she had breast cancer after her first mammogram in 2019. The 47-year-old jewelry designer had a lumpectomy, underwent radiation and took Tamoxifen. In 2025 she began feeling tired, bloated and anxious.
Her physicians advised against hormone replacement therapy but offered few alternatives. Teng consulted a menopause specialist from Midi Health who recommended vitamins, supplements, diet and lifestyle changes. She lives in a Boston suburb.
Megan Brownell, 52, watched her sister Tracey Kennedy, 55, complete surgery, chemotherapy and radiation for breast cancer. Kennedy had previously taken hormone pellets. Her gynecologist suggested testosterone while her oncologist disagreed.
Brownell is taking the non-hormonal drug Lynkuet and requires blood draws every three months to monitor liver enzymes. Temperatures in Phoenix reached 112 degrees Fahrenheit during the period covered. Brownell sets her thermostat at 73 degrees and uses fans during Zoom calls.
Dr. Eleanora Teplinsky, head of Breast and Gynecologic Medical Oncology at Valley Health System in New Jersey, said treating the whole person is vital. Dr. Mindy Goldman, chief clinical officer for Midi Health, noted that survivors are often told to be thankful they are alive and deal with side effects.
The Menopause Society acknowledges a lack of long-term data on how breast cancer survivors respond to hormone replacement therapy. The FDA recently removed a warning label from topical vaginal estrogen treatments. Dr.
Elizabeth Gilberg-Lenz, an obstetrician and gynecologist and 13-year breast cancer survivor on hormone replacement therapy, said shared decision making requires offering all options.
Single source — no framing comparison available.
motherjones.comA University of Bristol researcher collected samples from Signy Island showing distinct snow and glacier algae communities. The findings, published in ISME Communications, indicate these ecosystems may respond differently to warming than those on the Greenland Ice Sheet.
winnipegfreepress.comThe administration reached a $129 million settlement with Duke Energy to terminate an offshore wind lease off North Carolina. The agreement is the fourth such payment made to cancel wind projects.
wccftech.comRocket Lab announced plans on June 29 to buy Iridium at $54 per share. The transaction values the satellite operator at $8 billion and remains subject to closing.